Prevalence and Overlap of Cardiovascular, Kidney, and Metabolic Diseases in Korea: A Population-based Study
NCT07673822
Body Weight, Cardiovascular Risk
Seoul, South Korea
View Trial DetailsNCT Number: NCT07266220
This study is being done at Assiut University to look for early signs of hardening of the arteries (atherosclerosis) in people who have both diabetes and chronic kidney disease (CKD). Many patients with these conditions are at higher risk of heart disease and stroke, but the disease can develop quietly without symptoms.
We will use a safe, non-invasive test called carotid Doppler ultrasound, which uses sound waves to check the neck arteries (carotid arteries) for early changes. The goal is to see how often these early changes occur in patients with diabetes and CKD, and whether the findings relate to their kidney function, blood sugar control, and other health factors.
This research may help doctors detect vascular problems earlier and guide better prevention strategies for patients at risk.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Time frame: At baseline (single assessment at enrollment).
Carotid Doppler ultrasound will be performed once at study entry to measure carotid intima-media thickness and detect the presence of carotid plaque. The percentage of patients with subclinical carotid atherosclerosis will be estimated among adults with type 2 diabetes mellitus and stage 3 chronic kidney disease.
Abdallah Ali Mohammed
Other
Screening for Subclinical Atherosclerosis in Diabetic CKD Using Carotid Doppler
Acronym: DiCKD-CAROTID
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07673822
Body Weight, Cardiovascular Risk
Seoul, South Korea
View Trial DetailsNCT05365438
Arterial Occlusive Diseases, Arteriosclerosis
Seongnam-si, Gyeonggi-do, South Korea
View Trial DetailsNCT05365425
Arterial Occlusive Diseases, Arteriosclerosis
Seongnam-si, Gyeonggi-do, South Korea
View Trial DetailsNCT05179668
Cardiomegaly, Cardiovascular Diseases
Feldbach, Austria
View Trial Details